INTUITIVE SURGICAL INC's ticker is ISRG and the CUSIP is 46120E602. A total of 917 filers reported holding INTUITIVE SURGICAL INC in Q2 2019. The put-call ratio across all filers is 2.07 and the average weighting 0.4%.
About INTUITIVE SURGICAL INC
Intuitive Surgical Inc: A Leader in Robotic Surgery
Intuitive Surgical Inc is a company that specializes in the development and manufacturing of robotic surgical systems. The company's flagship product, the da Vinci Surgical System, is a robotic platform that allows surgeons to perform minimally invasive surgeries with greater precision and control.
The da Vinci Surgical System has been used in over 7 million surgeries worldwide, and the company has a market capitalization of over $100 billion. The system is used in a variety of surgical procedures, including urology, gynecology, and general surgery.
Intuitive Surgical Inc has been a leader in the field of robotic surgery for over two decades. The company was founded in 1995, and the first da Vinci Surgical System was introduced in 2000. Since then, the company has continued to innovate and improve its technology, with the latest version of the system, the da Vinci Xi, being introduced in 2014.
The company's success can be attributed to its focus on innovation and its commitment to patient safety. The da Vinci Surgical System has been shown to reduce the risk of complications and improve patient outcomes, making it a popular choice among surgeons and patients alike.
In conclusion, Intuitive Surgical Inc is a company that has revolutionized the field of robotic surgery. Its da Vinci Surgical System has become the gold standard in minimally invasive surgery, and the company's commitment to innovation and patient safety has made it a leader in the industry. As the demand for minimally invasive surgery continues to grow, Intuitive Surgical Inc is well-positioned to continue its success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $135,411,237 | +14.0% | 304,398 | +2.3% | 0.97% | +14.5% |
| Q1 2024 | $118,763,214 | +19.2% | 297,585 | +0.7% | 0.85% | +7.9% |
| Q4 2023 | $99,664,254 | +16.5% | 295,424 | +1.0% | 0.78% | +3.8% |
| Q3 2023 | $85,523,481 | -12.5% | 292,598 | +2.3% | 0.76% | -11.0% |
| Q2 2023 | $97,787,317 | +36.3% | 285,978 | +1.8% | 0.85% | +26.9% |
| Q1 2023 | $71,768,165 | -7.0% | 280,926 | -3.4% | 0.67% | -13.6% |
| Q4 2022 | $77,150,247 | +10645.2% | 290,749 | +12116.3% | 0.77% | +12800.0% |
| Q1 2022 | $718,000 | -17.0% | 2,380 | -1.1% | 0.01% | -14.3% |
| Q4 2021 | $865,000 | +6.1% | 2,407 | +193.5% | 0.01% | +16.7% |
| Q3 2021 | $815,000 | -20.9% | 820 | -26.8% | 0.01% | -33.3% |
| Q2 2021 | $1,030,000 | +24.4% | 1,120 | 0.0% | 0.01% | +28.6% |
| Q1 2021 | $828,000 | -0.1% | 1,120 | +10.6% | 0.01% | -12.5% |
| Q4 2020 | $829,000 | +24.5% | 1,013 | +7.9% | 0.01% | +14.3% |
| Q3 2020 | $666,000 | +7.8% | 939 | -13.4% | 0.01% | 0.0% |
| Q2 2020 | $618,000 | -75.6% | 1,084 | -78.8% | 0.01% | -82.1% |
| Q1 2020 | $2,534,000 | -96.2% | 5,118 | -95.4% | 0.04% | -95.1% |
| Q4 2019 | $65,954,000 | +9.7% | 111,569 | +0.2% | 0.80% | +3.7% |
| Q3 2019 | $60,103,000 | +5.7% | 111,316 | +2.6% | 0.77% | +7.2% |
| Q2 2019 | $56,887,000 | -3.9% | 108,450 | +4.6% | 0.72% | -6.7% |
| Q1 2019 | $59,166,000 | +19.7% | 103,695 | +0.5% | 0.77% | +4.2% |
| Q4 2018 | $49,432,000 | -14.0% | 103,216 | +3.1% | 0.74% | 0.0% |
| Q3 2018 | $57,446,000 | +23.5% | 100,080 | +2.9% | 0.74% | +15.9% |
| Q2 2018 | $46,533,000 | +3095.9% | 97,252 | +2658.1% | 0.64% | +3105.0% |
| Q1 2018 | $1,456,000 | +10.5% | 3,526 | -2.4% | 0.02% | +5.3% |
| Q4 2017 | $1,318,000 | -5.8% | 3,611 | +169.9% | 0.02% | -13.6% |
| Q3 2017 | $1,399,000 | -0.1% | 1,338 | -10.7% | 0.02% | -12.0% |
| Q2 2017 | $1,401,000 | +19.4% | 1,498 | -2.2% | 0.02% | +13.6% |
| Q1 2017 | $1,173,000 | +13.9% | 1,531 | -5.7% | 0.02% | 0.0% |
| Q4 2016 | $1,030,000 | -4.1% | 1,624 | +9.6% | 0.02% | -8.3% |
| Q3 2016 | $1,074,000 | +163.9% | 1,482 | +84.1% | 0.02% | +100.0% |
| Q2 2013 | $407,000 | – | 805 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deuterium Capital Management, LLC | 18,000 | $5,261,220 | 12.64% |
| BENDER ROBERT & ASSOCIATES | 89,331 | $26,110,558 | 7.63% |
| Biondo Investment Advisors, LLC | 137,008 | $40,045,922 | 7.54% |
| J Arnold Wealth Management Co | 58,867 | $17,207,624 | 6.96% |
| Iron Triangle Partners LP | 142,000 | $41,505,180 | 6.07% |
| Martin Capital Advisors, LLP | 19,678 | $5,751,683 | 5.60% |
| MIG Capital, LLC | 102,150 | $29,857,424 | 5.53% |
| Westwind Capital | 57,972 | $16,946 | 5.21% |
| Nova R Wealth, Inc. | 25,256 | $7,381,959 | 5.10% |
| GAGNON SECURITIES LLC | 66,229 | $19,358,077 | 4.85% |